A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, active controlled, multi-center, parallel group study comparing
HSK3486 with Propofol, in patients undergoing a colonoscopy.
Phase:
Phase 2
Details
Lead Sponsor:
Sichuan Haisco Pharmaceutical Group Co., Ltd Sichuan Haisco Pharmaceutical Group Co., Ltd.